Feed HELX
HE

Franklin Genomic Advancements ETF HELX CBOE · Financials · United States

$42.51 +0.00% +$0.00

Summary

Franklin Genomic Advancements ETF is an ETF - a fund traded on an exchange like a stock - run by Franklin Templeton. Positions inside: 70. The ten largest make up 47% of the fund.

Yearly costs
0.50%
Fund size
$34.0M
Positions
70
Dividend yield
0.34%
Running since
2020

What speaks for it

Nothing stands out in its favour.

What to watch

  • 97% of the fund is in one sector (Healthcare).
  • 95% of the fund is in one country (United States).
  • Costs of 0.50% a year are above the middle of comparable funds (0.45%).
  • In the last five years its price once dropped by 59% from its high.
  • A small fund with $34.0M under management; small funds get closed more often.
  • It trades little: only about $220.0K changes hands a day.

A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.

Price

Performance

1 month
+3.4%
3 months
+5.0%
This year
+17%
1 year
+22%
3 years
+57%
5 years
-17%
Avg. market cap
$69.1B
P/E
-
Forward P/E
-
P/S
10.2x
P/B
6.7x
P/FCF
37.7x
EV/EBITDA
29.3x
Dividend yield
0.06%
ROIC
-9.4%
ROE
7.3%
Gross margin
67.2%
Operating margin
-40.6%
Net margin
-36.7%
Payout ratio
-
Net debt/EBITDA
1.2x
Beta
0.98

Weighted average of the 50 largest companies, which make up 95% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.

What is inside?

Moderately concentrated
  1. 1
    GH
    Guardant Health GH 8.6%
  2. 2
    NT
    Natera NTRA 8.2%
  3. 3
    AD
    Adaptive Biotechnologies Corporation ADPT 5.1%
  4. 4
    KR
    Krystal Biotech KRYS 4.9%
  5. 5
    LG
    Ligand Pharmaceuticals LGND 4.6%
  6. 6
    BB
    BridgeBio Pharma BBIO 3.5%
  7. 7
    TW
    Twist Bioscience TWST 3.2%
  8. 8
    LL
    Eli Lilly LLY 2.9%
  9. 9
    ME
    Medpace MEDP 2.9%
  10. 10
    UT
    United Therapeutics UTHR 2.8%

Positions in the fund: 70. The ten largest make up 47% of it.

Composition as of Nov 14, 2026.

Where is it spread?

One sector dominates

By sector

By country

By company size

By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.

Largest sector: Healthcare (97%). Largest country: United States (95%). Largest size group: Large cap (57%).

What does it cost me?

Expensive
A year from $10,000
$50.00
Over 20 years
$2,416

From every $10,000 invested the fund takes $50.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,416.

How has it done?

Losing value
A year on average, 5 years
-3.6%
Deepest drop
-59%
Yearly volatility
26%

Average yearly decline over the last five years: 3.6%. Deepest drop in these years: 59% below the earlier high.

Does it pay dividends?

Yes, it pays out
Yield
0.34%
Payments a year
1
Last payment
$0.14

Over the last 12 months it paid $0.14 per share, which is 0.34% of today's price. The last payment was $0.14 on Dec 30, 2025.

Is it easy to buy and sell?

It trades little
Traded a day
$220.0K
Shares a day
5.2K

On an average day about $220.0K of the fund changes hands.

How expensive are the companies inside?

Rather expensive
Average Bulios Score
48 out of 100

Weight by Bulios Fair Price

By Fair Price, 76% of the rated weight comes out as overvalued.

Counted from its largest companies (50), which make up 95% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.

Similar funds

Funds that hold much of the same. The overlap says how much of their weight they share with this fund.

Fund Domicile Size 1-year change Dividends
WD
WDNA WisdomTree BioRevolution Fund
United States 0.45% $2.93M +37% Pays out 31%
XM
XMLH.DE L&G Healthcare Technology & Innovation UCITS ETF
Ireland 0.49% $279.2M +40% Reinvests 29%
HT
HTEC Robo Global Healthcare Technology and Innovation ETF
United States 0.80% $68.5M +32% Pays out 28%
GN
GNOM Global X - Genomics & Biotechnology ETF
United States 0.50% $102.7M +43% Pays out 28%
IB
IBB iShares Biotechnology ETF
United States 0.44% $11.0B +29% Pays out 27%
XB
XBI SPDR S&P Biotech ETF
United States 0.35% $7.87B +32% Pays out 26%

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy